Results 101 to 110 of about 335,762 (303)

Nonclinical Development of BCG Replacement Vaccine Candidates

Vaccines, 2013
The failure of current Mycobacterium bovis bacille Calmette–Guérin (BCG) vaccines, given to neonates to protect against adult tuberculosis and the risk of using these live vaccines in HIV-infected infants, has emphasized the need for generating new, more
Bernd Eisele, Martin Gengenbacher, Reginald Kidd, David McCown, Sheldon Morris, Steven Derrick, David Hokey, Dominick Laddy, Rosemary Chang, Megan Fitzpatrick, Leander Grode, Kamalakannan Velmurugan, Stefan H.E. Kaufmann, John Fulkerson, Michael J. Brennan   +14 more
doaj   +1 more source

Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines. [PDF]

Toxins (Basel), 2023
Gupta S, Pellett S.
europepmc   +1 more source

Patent Landscape of Helminth Vaccines and Related Technologies [PDF]

, 2013
Executive Summary This report focuses on patent landscape analysis of technologies related to vaccines targeting parasitic worms, also known as helminths.
Burke, Rayna, Cavicchi, Jon R., Kowalski, Stanley P., Michaud-King, Jillian, Schroeder, John   +4 more
core   +1 more source

On Pediatric Vaccines and Catholic Social Teaching [PDF]

, 2018
Determining whether, and when, to get one\u27s children vaccinated has become an increasingly controversial decision, often leaving parents fearful of making the “wrong” choice.
Bilgrien, Byron, Cahill, Coleman, Eiser, Grady, Heyer, Johnson, Kant, Kelly, Largent, Massaro, Offit, Offit, Offit, Oshinsky, Plotkin, Rubio, Skloot, Sobrino, Tucker   +20 more
core   +2 more sources

Vaccines don't save lives, vaccination does [PDF]

The Lancet Regional Health - Western Pacific, 2021
openaire   +3 more sources

A Cryoprotectant‐Compatible Nanoporous Platform for Stable and Scalable Delivery of Biopharmaceuticals

Advanced Materials, EarlyView.
A cryoprotectant‐compatible nanoporous platform enables ambient‐stable and scalable delivery of gene editing therapeutics. By combining hierarchical pore architecture with optimized lyophilization chemistry, the system preserves Cas9‐RNP activity post‐freeze‐drying.
Sian Lee, Seongchan Kim, Jooyeun Chong, Min‐gyeong Kim, Kayeong Lim, Nan‐Ee Lee, Jahyun Koo, Jiheong Kang, Hyojin Lee   +8 more
wiley   +1 more source

Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017

Frontiers in Immunology, 2018
Bacille Calmette–Guerin (BCG) vaccine is widely used as a prevention strategy against tuberculosis. BCG is a live vaccine, usually given early in life in most countries.
Cristiane de Jesus Nunes-Santos, Cristiane de Jesus Nunes-Santos, Sergio D. Rosenzweig   +2 more
doaj   +1 more source

Studies on immunopathological changes induced by commercial IBD live vaccines in poultry birds. [PDF]

Sci Rep, 2023
Kajal S, Narang G, Jangir BL, Kundu P, Lather D, Chhabra R.   +5 more
europepmc   +1 more source

Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.

, 2005
Vaccines against bioterrorism agents offer the prospect of providing high levels of protection against airborne pathogens. However, the diversity of the bioterrorism threat means that it may be necessary to use several vaccines simultaneously.
Bedford, Richard, Funnell, Simon, Griffin, Kate, Morton, Margret, Phillpotts, Robert, Titball, Richard, Townson, Kate, Williamson, Diane   +7 more
core   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

Advanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source